v3.24.0.1
Fourth Quarter Financial Results (unaudited) (Tables)
 12 Months Ended
Dec. 31, 2023
Quarterly Financial Information Disclosure [Abstract]  
Schedule of fourth quarter financial results
quarter ended December 31 (in millions except per share data)2023
Net revenues$14,301 
Gross margin8,597 
Net earnings attributable to AbbVie Inc.
822 
Basic earnings per share attributable to AbbVie Inc.$0.46 
Diluted earnings per share attributable to AbbVie Inc.$0.46 
Cash dividends declared per common share$1.55